Reporting Guidelines

SCIENTIFIC REPORTING STANDARDS

Reporting Guidelines

Promoting transparency, completeness and reproducibility in pharmaceutical research.

CRJPAS encourages authors to follow internationally recognized reporting guidelines appropriate to the design and methodology of their research.

Reporting guidelines support transparent communication of research methods and findings, enabling scientific evaluation, reproducibility and evidence synthesis.

Recommended Reporting Standards

Guideline Applicable Study Design
CONSORT 2025 Randomized controlled trials
PRISMA 2020 Systematic reviews and meta-analyses
STROBE Observational studies
CARE Clinical case reports
ARRIVE 2.0 Animal research
STARD Diagnostic accuracy studies
SPIRIT 2025 Clinical trial protocols
CHEERS 2022 Health economic evaluations

Reporting Checklists

Where a relevant reporting guideline exists, authors should prepare their manuscripts in accordance with the applicable checklist and submit the completed checklist if requested by the editorial office.

Clinical Trial Registration

Clinical trials must satisfy applicable prospective registration and research ethics requirements. Authors should disclose the clinical trial registry, registration number and relevant registration dates.

Data and Statistical Transparency

Authors should describe statistical methods, sample size considerations, primary outcomes, uncertainty measures, missing data and any relevant methodological limitations sufficiently for scientific evaluation.

Official Resources

Scientific Transparency

Reporting guidelines improve the completeness of scientific reporting but do not replace appropriate study design, ethical approval, methodological quality or independent peer review.